Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity

被引：44

作者：

Tam, Eric M. ^{[1
]}

Fulton, Ross B. ^{[1
]}

Sampson, James F. ^{[1
]}

Muda, Marco ^{[1
]}

Camblin, Adam ^{[1
]}

Richards, Jennifer ^{[1
]}

Koshkaryev, Alexander ^{[1
]}

Tang, Jian ^{[1
]}

Kurella, Vinodh ^{[1
]}

Jiao, Yang ^{[1
]}

Xu, Lihui ^{[1
]}

Zhang, Kathy ^{[1
]}

Kohli, Neeraj ^{[1
]}

Luus, Lia ^{[1
]}

Hutto, Elizabeth ^{[2
]}

Kumar, Sandeep ^{[1
]}

Lulo, James ^{[1
]}

Paragas, Violette ^{[1
]}

Wong, Christina ^{[1
]}

Suchy, James ^{[1
]}

Grabow, Stephanie ^{[1
]}

Dugast, Anne-Sophie ^{[1
]}

Zhang, Hong ^{[1
]}

Depis, Fabien ^{[1
]}

Feau, Sonia ^{[1
]}

Jakubowski, Aniela ^{[1
]}

Qiao, Wenlian ^{[1
]}

Craig, Galina ^{[1
]}

Razlog, Maja ^{[1
]}

Qiu, James ^{[1
]}

Zhou, Yu ^{[3
]}

Marks, James D. ^{[3
]}

Croft, Michael ^{[4
,5
]}

Drummond, Daryl C. ^{[1
]}

Raue, Andreas ^{[1
]}

机构：

[1] Merrimack Pharmaceut Inc, Cambridge, MA 02139 USA

[2] Histosci Res Labs, Mt Jackson, VA 22842 USA

[3] Univ Calif San Francisco, San Francisco, CA 94110 USA

[4] La Jolla Inst Immunol, La Jolla, CA 92037 USA

[5] Univ Calif San Diego, La Jolla, CA 92037 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2019年 / 11卷 / 512期

关键词：

TUMOR-NECROSIS-FACTOR; FC-GAMMA RECEPTORS; EXPRESSION; MOUSE; EFFECTOR; CANCER; COSTIMULATOR; ANTI-PD-L1; BLOCKADE; SURVIVAL;

D O I：

10.1126/scitranslmed.aax0720

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Tumor necrosis factor receptor 2 (TNFR2) is the alternate receptor for TNF and can mediate both pro- and anti-inflammatory activities of T cells. Although TNFR2 has been linked to enhanced suppressive activity of regulatory T cells (T-regs) in autoimmune diseases, the viability of TNFR2 as a target for cancer immunotherapy has been under-appreciated. Here, we show that new murine monoclonal anti-TNFR2 antibodies yield robust antitumor activity and durable protective memory inmultiplemouse cancer cell linemodels. The antibodies mediate potent Fc-dependent T cell costimulation and do not result in significant depletion of T-regs. Corresponding human agonistic monoclonal anti-TNFR2 antibodies were identified and also had antitumor effects in humanized mousemodels. Anti-TNFR2 antibodies could be developed as a novel treatment option for patients with cancer.

引用

页数：15

共 53 条

[1] Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
Agata, Y
Kawasaki, A
Nishimura, H
Ishida, Y
Tsubata, T
Yagita, H
Honjo, T
[J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) : 765 - 772
[2] Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a
Arduin, E.
Arora, S.
Bamert, P. R.
Kuiper, T.
Popp, S.
Geisse, S.
Grau, R.
Calzascia, T.
Zenke, G.
Kovarik, J.
[J]. MOLECULAR IMMUNOLOGY, 2015, 63 (02) : 456 - 463
[3] Regulation of TCR-mediated T cell activation by TNF-RII
Aspalter, RM
Eibl, MM
Wolf, HM
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (04) : 572 - 582
[4] Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity
Atretkhany, Kamar-Sulu N.
Mufazalov, Ilgiz A.
Dunst, Josefine
Kuchmiy, Anna
Gogoleva, Violetta S.
Andruszewski, David
Drutskaya, Marina S.
Faustman, Denise L.
Schwabenland, Marius
Prinz, Marco
Kruglov, Andrey A.
Waisman, Ari
Nedospasov, Sergei A.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (51) : 13051 - 13056
[5] Properties of mouse and human IgG receptors and their contribution to disease models
Bruhns, Pierre
[J]. BLOOD, 2012, 119 (24) : 5640 - 5649
[6] TNF-α is critical for antitumor but not antiviral T cell immunity in mice
Calzascia, Thomas
Pellegrini, Marc
Hall, Hakan
Sabbagh, Laurent
Ono, Nobuyuki
Elford, Alisha R.
Mak, Tak W.
Ohashi, Pamela S.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) : 3833 - 3845
[7] Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Chen, Xin
Subleski, Jeffrey J.
Kopf, Heather
Howard, O. M. Zack
Maennel, Daniela N.
Oppenheim, Joost J.
[J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (10) : 6467 - 6471
[8] Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Chen, Xin
Oppenheim, Joost J.
[J]. SCIENCE SIGNALING, 2017, 10 (462)
[9] Expression of Costimulatory TNFR2 Induces Resistance of CD4+FoxP3- Conventional T Cells to Suppression by CD4+ FoxP3+ Regulatory T Cells
Chen, Xin
Hamano, Ryoko
Subleski, Jeffrey J.
Hurwitz, Arthur A.
Howard, O. M. Zack
Oppenheim, Joost J.
[J]. JOURNAL OF IMMUNOLOGY, 2010, 185 (01) : 174 - 182
[10] Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
Chin, S. Michael
Kimberlin, Christopher R.
Roe-Zurz, Zygy
Zhang, Pamela
Xu, Allison
Liao-Chan, Sindy
Sen, Debasish
Nager, Andrew R.
Oakdale, Nicole Schirle
Brown, Colleen
Wang, Feng
Yang, Yuting
Lindquist, Kevin
Yeung, Yik Andy
Salek-Ardakani, Shahram
Chaparro-Riggers, Javier
[J]. NATURE COMMUNICATIONS, 2018, 9

← 1 2 3 4 5 6 →